{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:24:54Z","timestamp":1789683894661,"version":"4.0.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The European Society of Cardiology recently identified non-dilated left ventricular cardiomyopathy (NDLVC) as a distinct clinical entity. This study aimed to determine the prevalence and prognosis of NDLVC in a specific cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This retrospective cohort analysis included patients referred for routine cardiac magnetic resonance (CMR) and who underwent stress myocardial perfusion or viability assessment from September 2017 to July 2020. Patients with coronary artery disease (CAD) from history or CMR imaging were excluded. Participants were categorized into dilated cardiomyopathy (DCM), NDLVC, and control groups. NDLVC was defined as the presence of non-ischemic LGE or isolated global left ventricular hypokinesia without left ventricular dilatation. The primary endpoints were all-cause mortality or heart failure events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 4377 CMR patients, 2278 patients remain after the exclusion. Mean age was 66.3\u2009\u00b1\u200913.2 years, and 60.4% were females. Upon categorization, there were 1996 controls (87.6%), 172 DCM patients (7.6%), and 110 NDLVC patients (4.8%). Among the NDLVC patients, 64 patients (58.2%) had non-ischemic LGE, which included mid-wall, subepicardial, patchy and right ventricular insertion types. Over a median follow-up of 37.5 months, DCM patients exhibited higher rates of composite outcomes than NDLVC and control patients. Likewise, NDLVC patients also had significantly greater rates of composite outcomes and heart failure events than the controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NDLVC had a prevalence of 2.5% among routine stress or viability CMR cases and had a significantly higher rate of clinical outcomes than the controls but lower than DCM patients. These findings underscore the distinct clinical significance of NDLVC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Question<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>What is the prevalence and clinical prognosis of non-dilated left ventricular cardiomyopathy (NDLVC) in patients undergoing routine stress or viability cardiac MRI?<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Findings<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>NDLVC was present in 2.5% of patients undergoing routine stress or viability cardiac MRI and was associated with worse clinical outcomes than controls, but more favorable than dilated cardiomyopathy.<\/jats:italic>\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:bold>\n                        <jats:italic>Clinical relevance<\/jats:italic>\n                      <\/jats:bold>\n                      <jats:italic>Identifying NDLVC on routine cardiac magnetic resonance (CMR) provides prognostic value, helping to recognize patients at increased risk of heart failure events despite preserved left ventricular size.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00330-025-12072-4","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:19:55Z","timestamp":1761675595000},"page":"3066-3078","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and prognosis of non-dilated left ventricular cardiomyopathy in patients referred for cardiac magnetic resonance"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8684-2361","authenticated-orcid":false,"given":"Rungroj","family":"Krittayaphong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thammarak","family":"Songsangjinda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yodying","family":"Kaolawanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchalaporn","family":"Jirataiporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahthit","family":"Yindeengam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"12072_CR1","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron BJ, Towbin JA, Thiene G et al (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807\u20131816","journal-title":"Circulation"},{"key":"12072_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","volume":"64","author":"E Arbustini","year":"2014","unstructured":"Arbustini E, Narula N, Tavazzi L et al (2014) The MOGE(S) classification of cardiomyopathy for clinicians. J Am Coll Cardiol 64:304\u2013318","journal-title":"J Am Coll Cardiol"},{"key":"12072_CR3","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/j.jcmg.2017.11.034","volume":"11","author":"I Eitel","year":"2018","unstructured":"Eitel I, Stiermaier T, Lange T et al (2018) Cardiac magnetic resonance myocardial feature tracking for optimized prediction of cardiovascular events following myocardial infarction. JACC Cardiovasc Imaging 11:1433\u20131444","journal-title":"JACC Cardiovasc Imaging"},{"key":"12072_CR4","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jcmg.2022.01.016","volume":"15","author":"AG Raafs","year":"2022","unstructured":"Raafs AG, Vos JL, Henkens M et al (2022) Left atrial strain has superior prognostic value to ventricular function and delayed-enhancement in dilated cardiomyopathy. JACC Cardiovasc Imaging 15:1015\u20131026","journal-title":"JACC Cardiovasc Imaging"},{"key":"12072_CR5","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR et al (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 44:3503\u20133626","journal-title":"Eur Heart J"},{"key":"12072_CR6","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","volume":"37","author":"YM Pinto","year":"2016","unstructured":"Pinto YM, Elliott PM, Arbustini E et al (2016) Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 37:1850\u20131858","journal-title":"Eur Heart J"},{"key":"12072_CR7","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"K Zeppenfeld","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M et al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43:3997\u20134126","journal-title":"Eur Heart J"},{"key":"12072_CR8","doi-asserted-by":"publisher","first-page":"9252","DOI":"10.1007\/s12410-013-9252-y","volume":"7","author":"DM Higgins","year":"2014","unstructured":"Higgins DM, Moon JC (2014) Review of T1 mapping methods: comparative effectiveness including reproducibility issues. Curr Cardiovasc Imaging Rep 7:9252","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"12072_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM et al (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19:75","journal-title":"J Cardiovasc Magn Reson"},{"key":"12072_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12968-020-00683-3","volume":"22","author":"N Kawel-Boehm","year":"2020","unstructured":"Kawel-Boehm N, Hetzel SJ, Ambale-Venkatesh B et al (2020) Reference ranges (\u201cnormal values\u201d) for cardiovascular magnetic resonance (CMR) in adults and children: 2020 update. J Cardiovasc Magn Reson 22:87","journal-title":"J Cardiovasc Magn Reson"},{"key":"12072_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12968-016-0269-7","volume":"18","author":"G Pedrizzetti","year":"2016","unstructured":"Pedrizzetti G, Claus P, Kilner PJ, Nagel E (2016) Principles of cardiovascular magnetic resonance feature tracking and echocardiographic speckle tracking for informed clinical use. J Cardiovasc Magn Reson 18:51","journal-title":"J Cardiovasc Magn Reson"},{"key":"12072_CR12","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1093\/ehjci\/jey042","volume":"19","author":"LP Badano","year":"2018","unstructured":"Badano LP, Kolias TJ, Muraru D et al (2018) Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/Industry Task Force to standardize deformation imaging. Eur Heart J Cardiovasc Imaging 19:591\u2013600","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"12072_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","volume":"18","author":"P Haaf","year":"2016","unstructured":"Haaf P, Garg P, Messroghli DR, Broadbent DA, Greenwood JP, Plein S (2016) Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson 18:89","journal-title":"J Cardiovasc Magn Reson"},{"key":"12072_CR14","doi-asserted-by":"publisher","first-page":"C130","DOI":"10.1093\/eurheartjsupp\/suad015","volume":"25","author":"GD Aquaro","year":"2023","unstructured":"Aquaro GD, De Gori C, Faggioni L et al (2023) Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies. Eur Heart J Suppl 25:C130\u2013C136","journal-title":"Eur Heart J Suppl"},{"key":"12072_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.119.010105","volume":"13","author":"AC Alba","year":"2020","unstructured":"Alba AC, Gaztanaga J, Foroutan F et al (2020) Prognostic value of late gadolinium enhancement for the prediction of cardiovascular outcomes in dilated cardiomyopathy: an international, multi-institutional study of the MINICOR Group. Circ Cardiovasc Imaging 13:e010105","journal-title":"Circ Cardiovasc Imaging"},{"key":"12072_CR16","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.jcmg.2020.11.006","volume":"14","author":"A Mandawat","year":"2021","unstructured":"Mandawat A, Chattranukulchai P, Mandawat A et al (2021) Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes. JACC Cardiovasc Imaging 14:1338\u20131350","journal-title":"JACC Cardiovasc Imaging"},{"key":"12072_CR17","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1002\/ehf2.12865","volume":"7","author":"J Wang","year":"2020","unstructured":"Wang J, Yang F, Wan K, Mui D, Han Y, Chen Y (2020) Left ventricular midwall fibrosis as a predictor of sudden cardiac death in non-ischaemic dilated cardiomyopathy: a meta-analysis. ESC Heart Fail 7:2184\u20132192","journal-title":"ESC Heart Fail"},{"key":"12072_CR18","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1177\/08465371221119713","volume":"74","author":"C Urzua Fresno","year":"2023","unstructured":"Urzua Fresno C, Sanchez Tijmes F, Shaw KE et al (2023) Cardiac imaging in myocarditis: current evidence and future directions. Can Assoc Radiol J 74:147\u2013159","journal-title":"Can Assoc Radiol J"},{"key":"12072_CR19","doi-asserted-by":"crossref","unstructured":"Polte CL, Bobbio E, Bollano E et al (2022) Cardiovascular magnetic resonance in myocarditis. Diagnostics (Basel) 12:399","DOI":"10.3390\/diagnostics12020399"},{"key":"12072_CR20","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2017.08.044","volume":"70","author":"GD Aquaro","year":"2017","unstructured":"Aquaro GD, Perfetti M, Camastra G et al (2017) Cardiac MR with late gadolinium enhancement in acute myocarditis with preserved systolic function: ITAMY study. J Am Coll Cardiol 70:1977\u20131987","journal-title":"J Am Coll Cardiol"},{"key":"12072_CR21","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/j.jacc.2017.08.050","volume":"70","author":"C Grani","year":"2017","unstructured":"Grani C, Eichhorn C, Biere L et al (2017) Prognostic value of cardiac magnetic resonance tissue characterization in risk stratifying patients with suspected myocarditis. J Am Coll Cardiol 70:1964\u20131976","journal-title":"J Am Coll Cardiol"},{"key":"12072_CR22","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000531534","volume":"148","author":"E Dziewiecka","year":"2023","unstructured":"Dziewiecka E, Winiarczyk M, Wisniowska-Smialek S et al (2023) Comparison of clinical course and outcomes between dilated and hypokinetic non-dilated cardiomyopathy. Cardiology 148:395\u2013401","journal-title":"Cardiology"},{"key":"12072_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10554-020-01966-7","volume":"37","author":"M Polacin","year":"2021","unstructured":"Polacin M, Kapos I, Gastl M et al (2021) Comparison of 3D and 2D late gadolinium enhancement magnetic resonance imaging in patients with acute and chronic myocarditis. Int J Cardiovasc Imaging 37:305\u2013313","journal-title":"Int J Cardiovasc Imaging"},{"key":"12072_CR24","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jcmg.2022.10.018","volume":"16","author":"A Stevenson","year":"2023","unstructured":"Stevenson A, Bray JJH, Tregidgo L et al (2023) Prognostic value of late gadolinium enhancement detected on cardiac magnetic resonance in cardiac sarcoidosis. JACC Cardiovasc Imaging 16:345\u2013357","journal-title":"JACC Cardiovasc Imaging"},{"key":"12072_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.advms.2020.11.002","volume":"66","author":"R Kazimierczyk","year":"2021","unstructured":"Kazimierczyk R, Malek LA, Szumowski P et al (2021) Prognostic value of late gadolinium enhancement mass index in patients with pulmonary arterial hypertension. Adv Med Sci 66:28\u201334","journal-title":"Adv Med Sci"},{"key":"12072_CR26","doi-asserted-by":"publisher","first-page":"e579","DOI":"10.1161\/CIR.0000000000000455","volume":"134","author":"B Bozkurt","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J et al (2016) Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation 134:e579\u2013e646","journal-title":"Circulation"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12072-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-025-12072-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-025-12072-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:19:27Z","timestamp":1774883967000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-025-12072-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["12072"],"URL":"https:\/\/doi.org\/10.1007\/s00330-025-12072-4","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Dr. Rungroj Krittayaphong.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"All authors declare no personal or professional conflicts of interest relating to any aspect of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Two of the authors have significant statistical expertise (Rungroj Krittayaphong and Ahthit Yindeengam).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was not obtained due to the retrospective design of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The protocol for this study was approved by the Siriraj Institutional Review Board (COA no. Si 106\/2024).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}